Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04404569 |
| Title | Continued Treatment for Participants Enrolled in Studies of BXQ-350 |
| Acronym | ETERNITI |
| Recruitment | Enrolling by invitation |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bexion Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Kentucky Markey Cancer Center | Lexington | Kentucky | 40536 | United States | Details | |
| University of Cincinnati Barrett Center | Cincinnati | Ohio | 45219 | United States | Details | |
| The Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details |